Selected article for: "analysis study and association analysis"
Author: Yamada, Takayuki; Wakabayashi, Mako; Yamaji, Takahiro; Chopra, Nitin; Mikami, Takahisa; Miyashita, Hirotaka; Miyashita, Satoshi
Title: Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): A systematic review and meta-analysis
  • Cord-id: vw6vg5b7
  • Document date: 2020_6_10
    • ID: vw6vg5b7
    Snippet: BACKGROUND: Since December 2019, coronavirus 2019 (COVID-19) has spread worldwide. Identifying poor prognostic factors is helpful for risk stratification. In this meta-analysis, we investigated the association between severe COVID-19 and a change in white blood cell (WBC) count, an elevation of C-reactive protein (CRP), and fever. Moreover, we aimed to evaluate the diagnostic accuracy of leukocytosis and an elevation of CRP. METHODS: We performed a systematic search of PubMed, EMBASE, Scopus, an
    Document: BACKGROUND: Since December 2019, coronavirus 2019 (COVID-19) has spread worldwide. Identifying poor prognostic factors is helpful for risk stratification. In this meta-analysis, we investigated the association between severe COVID-19 and a change in white blood cell (WBC) count, an elevation of C-reactive protein (CRP), and fever. Moreover, we aimed to evaluate the diagnostic accuracy of leukocytosis and an elevation of CRP. METHODS: We performed a systematic search of PubMed, EMBASE, Scopus, and the Cochrane Library through April 20th, 2020. The odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. A sensitivity analysis was conducted according to the study size (>200 or <200) and median age (>55 or <55). Meta-regression analyses were conducted to examine possible sources of heterogeneity. We calculated the diagnostic accuracy of leukocytosis and CRP. RESULTS: Eighteen studies with 3278 patients were selected. Fever, leukocytosis, and elevated CRP were associated with poor outcomes (OR (95% CI) 1.63 (1.06–2.51), 4.51 (2.53–8.04), and 11.97 (4.97–28.8), respectively). Leukopenia was associated with a better prognosis (OR 0.56, 95% CI 0.40–0.78). Sensitivity analyses showed similar tendencies. Meta-regression analysis for leukocytosis indicated that age, dyspnea, and hypertension contributed to heterogeneity. The pooled area under the leukocytosis and CRP curves were 0.70 (0.64–0.76) and 0.89 (0.80–0.99), respectively. CONCLUSION: In patients with COVID-19, fever, leukocytosis, and an elevated CRP were associated with severe outcomes. Leukocytosis and CRP on arrival may predict poor outcomes.

    Search related documents:
    Co phrase search for related documents
    • abstract title and acute ards respiratory distress syndrome: 1
    • abstract title and acute distress syndrome: 1
    • abstract title and acute phase: 1, 2, 3, 4, 5, 6, 7
    • abstract title and acute respiratory distress syndrome: 1
    • abstract title and acute respiratory distress syndrome ards: 1
    • abstract title and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute ards and admission crp: 1, 2, 3, 4, 5, 6, 7, 8
    • acute ards and low temperature: 1, 2
    • acute ards respiratory distress syndrome and admission crp: 1, 2, 3, 4, 5, 6, 7, 8
    • acute ards respiratory distress syndrome and low temperature: 1, 2
    • acute distress syndrome and admission crp: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute distress syndrome and low temperature: 1, 2, 3, 4
    • acute phase and admission crp: 1, 2, 3, 4, 5, 6, 7, 8
    • acute phase and low temperature: 1
    • acute phase protein and admission crp: 1
    • acute respiratory distress syndrome and admission crp: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute respiratory distress syndrome and low temperature: 1, 2, 3, 4
    • acute respiratory distress syndrome ards and admission crp: 1, 2, 3, 4, 5, 6, 7, 8
    • acute respiratory distress syndrome ards and low temperature: 1, 2